|
|
(55 intermediate revisions by 2 users not shown) |
Line 3: |
Line 3: |
| {{CMG}}; {{AE}} {{Preeti}} | | {{CMG}}; {{AE}} {{Preeti}} |
|
| |
|
| {| class="wikitable"
| |
| ! colspan="3" rowspan="2" |
| |
| ! rowspan="2" |Pathophysiology
| |
| ! rowspan="2" |Symptoms
| |
| ! rowspan="2" |History
| |
| ! rowspan="2" |Physical Examination
| |
| ! colspan="3" |Laboratory Findings
| |
| |-
| |
| !Immunochemistry
| |
| !Blood work
| |
| !Biospy/CT/CXR
| |
| |-
| |
| | rowspan="9" |'''Infections'''
| |
| | rowspan="3" |'''Bacterial'''
| |
| | rowspan="2" |'''Syphilis'''
| |
| | rowspan="2" |
| |
| * Syphilis is caused by a [[spirochete]], [[Treponema pallidum|''Treponema pallidum'']].
| |
|
| |
|
| * It has an average incubation period of 3 - 12 weeks.
| | ==References== |
| * Spirochete penetrates intact mucous membrane or microscopic dermal abrasions and rapidly enters systemic circulation with the [[central nervous system]] being invaded during the early phase of infection.
| | {{Reflist|2}} |
| * The histopathological hallmark findings are endarteritis and plasma cell-rich infiltrates reflecting a delayed-type of hypersensitivity reaction to the spirochete.
| |
| | rowspan="2" |
| |
| '''Primary syphilis'''
| |
| * Mononuclear leukocytic infiltration, [[macrophages]], and [[lymphocytes]]
| |
| * Swelling and proliferation of small blood vessels
| |
| '''Secondary syphilis'''
| |
| * Swelling and dilatation of blood vessels in the [[dermis]]
| |
| * Epidermal [[hyperplasia]] and neutrophilic infiltration
| |
| * Inflammatory cell infiltrate, predominantly [[plasma cell]]
| |
| '''Tertiary syphilis'''
| |
| * Small vessel inflammation ([[endarteritis obliterans]])
| |
| * Granulomatous lesions ([[gumma]]) containing central necrosis, inflammatory cells, such as [[lymphocytes]], [[macrophages]], [[plasma cells]] and [[Fibroblast|fibroblasts]].
| |
| | rowspan="2" |
| |
| | rowspan="2" |
| |
| | rowspan="2" | | |
| *
| |
|
| |
|
| * A presumptive diagnosis of syphilis is possible with the use of two types of serologic tests.
| | {{WH}} |
| :* Nontreponemal tests (e.g., [[VDRL|venereal disease research laboratory (VDRL)]] and [[RPR|rapid plasma reagent test]]) and
| | {{WS}} |
| :* Treponemal tests (e.g., [[FTA-ABS|fluorescent treponemal antibody absorbed (FTA-ABS) tests]], the ''T. pallidum'' passive particle agglutination (TP-PA) assay, various [[Enzyme linked immunosorbent assay (ELISA)|enzyme immunoassays]], and [[Chemiluminescence|chemiluminescence immunoassays]]). | | [[Category: (name of the system)]] |
| |
| |
| | rowspan="2" |Darkfield examinations and tests to detect ''[[T. pallidum]].''
| |
| |-
| |
| |
| |
| |-
| |
| |'''Brucellosis'''
| |
| |[[humans]] could be infected by eating undercook meat or raw [[Dairy product|dairy]] products, inhalation of the [[bacteria]] and direct contact of bacteria with [[skin]] [[wounds]] or [[Mucous membranes|mucous membranes.]] Following transmission, [[white blood cells]] phagocyte the pathogen and transports it via hematologic or [[Lymphatic system|lymphatic route]] to different organs specially to those of the [[reticuloendothelial system]].
| |
| |
| |
| * Fever
| |
| * Rash
| |
| * Abdominal pain
| |
| * weightloss
| |
| * Painful lymphadenopathy
| |
| * hepatosplenomegaly
| |
| * arthritis
| |
| |
| |
| | |
| |
| |
| |
| |
| * [[Lymphocytosis|Relative lymphocytosis]]
| |
| * positive titer of anti-[[Brucella|b''rucella'']] [[antibodies]] on serological testing
| |
| * There are two types of serological tests, based on:
| |
| ** Antibody production against [[lipopolysaccharide]]
| |
| ** Antibody production against other [[bacterial]] [[antigens]]
| |
| |
| |
| |
| |
| * [[Brucella|''Brucella'']] is most commonly isolated from blood cultures (blood cultures are positive between the 7th and 21st day)
| |
| |-
| |
| | rowspan="4" |'''Viral'''
| |
| |'''infectious mononucleosis'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |'''cytomegalovirus'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |'''human immunodeficiency virus'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |'''cat scratch fever'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |'''Mycobacterial'''
| |
| |'''tuberculosis'''
| |
| |
| |
| * Mostly in endemic areas
| |
| |Symptoms include [[productive cough]],[[night sweats]], [[fever]] and [[weight loss]]
| |
| |
| |
| |
| |
| |
| |
| * [[Sputum]] smear positive for [[acid-fast bacilli]]<nowiki/>and nucleic acid amplification tests (NAAT) is used on sputum or any sterile fluid for rapid diagnosis and is positive for mycobacteria.
| |
| |
| |
| |
| |
| * CXR and CT demonstrates [[Internal|cavities]] in the upper lobe of the lung
| |
| |-
| |
| |'''Parasitic'''
| |
| |'''toxoplasmosis'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="4" |'''Autoimmune'''
| |
| | colspan="2" |'''Systemic lupus erythematosus'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" |'''Sjögren's syndrome'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" |'''Hydantoin derivatives'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" |'''Sarcoidosis'''
| |
| |
| |
| * More common in African-American females
| |
| * Often [[asymptomatic]] except for [[Lymphadenopathy|enlarged lymph nodes]]
| |
| * Associated with [[restrictive lung disease]]
| |
| * [[Erythema nodosum]]
| |
| * [[Lupus pernio]] (skin lesions on face resembling lupus)
| |
| * [[Bell's palsy|Bell palsy]]
| |
| * [[Epithelioid]] [[granuloma]]<nowiki/>s containing microscopic [[Schaumann bodies|Schaumann]] and asteroid bodies
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| * On CXR bilateral [[Lymphadenopathy|adenopathy]] and coarse reticular opacities are seen.
| |
| * CT of the chest demonstrates extensive [[Hilar lymphadenopathy|hilar]] and mediastinal adenopathy
| |
| * Additional findings on CT include [[fibrosis]] (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.
| |
| * Biopsy of lung shows non-[[caseating]][[granuloma]]
| |
| |-
| |
| | rowspan="6" |'''Neoplasms'''
| |
| | colspan="2" rowspan="1" |'''Hodgkin's disease'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Chronic lymphocytic leukemia'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Small cell carcinoma of the lung'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Malignant histiocytosis'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Melanoma'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Germ cell neoplasms'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="5" |'''Other conditions'''
| |
| | colspan="2" rowspan="1" |'''Reactive lymphoid hyperplasia'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Lymphomatoid granulomatosis'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Dermatopathic lymphadenopathy'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Angioimmunoblastic lymphadenopathy'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | colspan="2" rowspan="1" |'''Giant lymph node hyperplasia (Castleman disease)'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |}
| |